Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.52M Buy
21,008
+14,980
+249% +$1.01M 0.04% 351
2017
Q1
$393K Sell
6,028
-3,146
-34% -$198K 0.01% 1628
2016
Q4
$574K Sell
9,174
-31,088
-77% -$1.9M 0.01% 1352
2016
Q3
$2.54M Buy
+40,262
New +$2.61M 0.06% 233
2016
Q2
Sell
-69,048
Closed -$3.94M 2910
2016
Q1
$3.94M Buy
+69,048
New +$3.85M 0.11% 96
2015
Q4
Sell
-13,700
Closed -$745K 3443
2015
Q3
$745K Sell
13,700
-3,246
-19% -$211K 0.01% 1137
2015
Q2
$1.14M Sell
16,946
-33,183
-66% -$2.17M 0.02% 748
2015
Q1
$2.94M Sell
50,129
-4,580
-8% -$277K 0.06% 242
2014
Q4
$3.58M Sell
54,709
-8,865
-14% -$559K 0.06% 220
2014
Q3
$3.67M Buy
63,574
+53,757
+548% +$2.98M 0.07% 216
2014
Q2
$554K Sell
9,817
-1,065
-10% -$55.9K 0.01% 1837
2014
Q1
$559K Sell
10,882
-466
-4% -$23.6K 0.01% 1846
2013
Q4
$599K Sell
11,348
-238
-2% -$11.7K 0.01% 1751
2013
Q3
$518K Buy
+11,586
New +$514K 0.01% 1970

Other funds holding ABBV

Virtu KCG Holdings's ABBV Position: Q2 2017 in Review

Virtu KCG Holdings increased its AbbVie (ABBV) stake by 249% in Q2 2017, buying an estimated $1.01M and bringing the position to 21,008 shares worth $1.52M. The position accounts for 0.04% of the portfolio, ranked #351.

Virtu KCG Holdings first reported a position in ABBV in Q3 2013 and has held it in 14 quarters since. The position peaked at $3.94M in Q1 2016. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Virtu KCG Holdings held 21,008 shares of AbbVie worth $1.52M as of Q2 2017.
  • Virtu KCG Holdings bought 14,980 AbbVie shares in Q2 2017, an estimated $1.01M.
  • AbbVie made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #351 holding.
  • Virtu KCG Holdings first reported a position in AbbVie in Q3 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's AbbVie position peaked at $3.94M in Q1 2016.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.